Immunologist’s lab demonstrates the power of B cells to gather, defend organs against cancer
Joshua Moreau, Ph.D., investigates vaccine methods to mobilize the cells to fight off disease, fend off future threats.
Research
More Research Stories
- Latest Stories
OHSU Knight Cancer Institute earns National Cancer Institute’s highest distinction
July 10, 2017
OHSU Knight Cancer Institute has been awarded the National Cancer Institute’s, NCI, premier status: Comprehensive Cancer Center.
Offering a helping hand
July 04, 2017
Using a 3D printer, Albert Chi, M.D. constructed a pair of prosthetic hands for a 6-year-old Astoria boy.
Patients with multiple sclerosis may benefit from over-the-counter therapy
July 03, 2017
An OHSU pilot study suggests the over-the-counter antioxidant lipoic acid holds promise in improving the lives of patients with secondary progressive multiple sclerosis.
Health insurance expansion linked to fewer sudden cardiac arrests
June 28, 2017
A new study shows the incidence of cardiac arrests declined significantly among people who acquired health insurance through the Affordable Care Act.
OHSU Knight Cancer Institute and Pacific Northwest National Laboratory team up to focus on a complex form of leukemia
June 27, 2017
The Office of Cancer Clinical Proteomics Research (OCCPR) at the National Cancer Institute (NCI) announced the institutes that will comprise the Proteogenomic Translational Research Centers, a group created to collaborate with NCI-sponsored clinical trials.
Technology expert joins the OHSU Knight Cancer Institute’s center for cancer early detection
June 22, 2017
Today the OHSU Knight Cancer Institute announced that internationally renowned bioengineering and technology expert Mike Heller, Ph.D., will join the institute’s Cancer Early Detection Advanced Research Center, or CEDAR, to lead its technology efforts.
Study finds nearly half of female cancer survivors experience symptoms of nerve damage, experience more falls well after treatment
June 19, 2017
A study of more than 500 cancer survivors found that many years after completing treatment, nearly half of women cancer survivors continued to experience chemotherapy-induced peripheral neuropathy, CIPN.
Review finds no definitive standard for identifying and treating veterans at risk for suicide
June 15, 2017
A systematic review of basic and clinical science research has revealed no definitive standard for detecting military veterans at risk of suicidal behavior, nor is there a clear standard of treatment to prevent suicide among U.S. veterans.
Study: Use of prefabricated blood vessels may revolutionize root canals
June 12, 2017
Researchers at OHSU have developed a process to engineer artificial blood vessels which are used to help regenerate teeth, possibly changing the way root canal treatments will be done in the future.
OHSU Knight Cancer Institute selected to join prestigious national consortium, receive $9.2 million
May 25, 2017
The National Cancer Institute has awarded a research team at the OHSU Knight Cancer Institute $9.2 million over five years to serve as a Research Center in the NCI’s Cancer Systems Biology Consortium, or CSBC.